Recruiting A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325 Conditions Anti-CD20 Therapy, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +11 more Locations Neurology Department, Hospital Gui de Chauliac — Montpellier, France View Trial Details
Completed COVID-19 Infection in Patients Receiving Anti-CD20 Therapy NCT04884477 Conditions Anti-CD20 Therapy, COVID-19, Convalescent Plasma, +12 more Locations Mayo Clinic — Rochester, Minnesota, United States View Trial Details
